Develops diagnostic tests for prostate cancer.
Dec 2025Revenue $108M/yrExpenses $122M/yr
Expected break-even Jan 2027Cash runway ≈ 8.7 years from Dec 2025
Figures by year
When will MDxHealth be profitable?
Its revenue and expense trends are projected to cross in Jan 2027. In the 12 months to Dec 2025, revenue was $108M and expenses $122M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $108M | $122M | −$14.4M |
| Dec 2024 | $90.0M | $115M | −$24.7M |
| Dec 2023 | $70.2M | $97.5M | −$27.3M |
| Dec 2022 | $37.1M | $75.0M | −$37.9M |
| Dec 2021 | $22.2M | $49.1M | −$26.8M |
| Dec 2020 | $18.5M | $45.6M | −$27.1M |
| Dec 2019 | $11.8M | $55.0M | −$43.2M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.